Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer

被引:75
|
作者
Liu, Yuanda [1 ]
Li, Changfeng [1 ]
Lu, Yaoping [2 ]
Liu, Chang [1 ]
Yang, Wei [2 ]
机构
[1] Jilin Univ, Dept Endoscopy Ctr, China Japan Union Hosp, Changchun, Peoples R China
[2] Jilin Univ, Coll Basic Med Sci, Dept Immunol, Changchun, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
关键词
immune tolerance; tumor microenvironment; gastric cancer; immunotherapy; tumor-infiltrating immune cells; EPITHELIAL-MESENCHYMAL TRANSITION; NATURAL-KILLER-CELLS; T-CELLS; GASTROESOPHAGEAL JUNCTION; PATHOLOGICAL FUNCTIONS; M2; POLARIZATION; PROMOTES; MACROPHAGES; FIBROBLASTS; ACTIVATION;
D O I
10.3389/fimmu.2022.1016817
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tumor microenvironment is the general term for all non-cancer components and their metabolites in tumor tissue. These components include the extracellular matrix, fibroblasts, immune cells, and endothelial cells. In the early stages of tumors, the tumor microenvironment has a tumor suppressor function. As the tumor progresses, tumor immune tolerance is induced under the action of various factors, such that the tumor suppressor microenvironment is continuously transformed into a tumor-promoting microenvironment, which promotes tumor immune escape. Eventually, tumor cells manifest the characteristics of malignant proliferation, invasion, metastasis, and drug resistance. In recent years, stress effects of the extracellular matrix, metabolic and phenotypic changes of innate immune cells (such as neutrophils, mast cells), and adaptive immune cells in the tumor microenvironment have been revealed to mediate the emerging mechanisms of immune tolerance, providing us with a large number of emerging therapeutic targets to relieve tumor immune tolerance. Gastric cancer is one of the most common digestive tract malignancies worldwide, whose mortality rate remains high. According to latest guidelines, the first-line chemotherapy of advanced gastric cancer is the traditional platinum and fluorouracil therapy, while immunotherapy for gastric cancer is extremely limited, including only Human epidermal growth factor receptor 2 (HER-2) and programmed death ligand 1 (PD-L1) targeted drugs, whose benefits are limited. Clinical experiments confirmed that cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), vascular endothelial growth factor receptor (VEGFR) and other targeted drugs alone or in combination with other drugs have limited efficacy in patients with advanced gastric cancer, far less than in lung cancer, colon cancer, and other tumors. The failure of immunotherapy is mainly related to the induction of immune tolerance in the tumor microenvironment of gastric cancer. Therefore, solving the immune tolerance of tumors is key to the success of gastric cancer immunotherapy. In this study, we summarize the latest mechanisms of various components of the tumor microenvironment in gastric cancer for inducing immune tolerance and promoting the formation of the malignant phenotype of gastric cancer, as well as the research progress of targeting the tumor microenvironment to overcome immune tolerance in the treatment of gastric cancer.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma
    Chen, Chen
    Wang, Zehua
    Ding, Yi
    Qin, Yanru
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [2] Tumor microenvironment-mediated chemoresistance in breast cancer
    Velaei, Kobra
    Samadi, Nasser
    Barazvan, Balal
    Rad, Jafar Soleimani
    BREAST, 2016, 30 : 92 - 100
  • [3] Clinical significance of the tumor microenvironment on immune tolerance in gastric cancer
    He, Xiangyang
    Guan, Xin-Yuan
    Li, Yan
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [4] Tumor Microenvironment-Mediated Immune Profiles Characterized by Distinct Survival Outcome and Immunotherapeutic Efficacy in Breast Cancer
    Xu, Lijun
    Hu, Yaomin
    Liu, Wenwen
    FRONTIERS IN GENETICS, 2022, 13
  • [5] The tumor immune-microenvironment in gastric cancer
    Fang, Fujin
    Zhang, Tiantian
    Li, Qiong
    Chen, Xiaowei
    Jiang, Fei
    Shen, Xiaobing
    TUMORI JOURNAL, 2022, 108 (06): : 541 - 551
  • [6] Deadly DAaRTS destroy cancer cells via a tumor microenvironment-mediated trigger
    McCann, James V.
    Null, Jamie L.
    Dudley, Andrew C.
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (07): : 2750 - 2753
  • [7] Immune Cell Interactions and Immune Checkpoints in the Tumor Microenvironment of Gastric Cancer
    Cozac-Szoke, Andreea-Raluca
    Cozac, Dan Alexandru
    Negovan, Anca
    Tinca, Andreea Catalina
    Vilaia, Alexandra
    Cocuz, Iuliu-Gabriel
    Sabau, Adrian Horatiu
    Niculescu, Raluca
    Chiorean, Diana Maria
    Tomut, Alexandru Nicusor
    Cotoi, Ovidiu Simion
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (03)
  • [8] Prognostic stratification of gastric cancer patients by intratumoral microbiota-mediated tumor immune microenvironment
    Gao, Wei
    Li, Feifei
    Wu, Tao
    Ji, Lei
    MICROBIAL PATHOGENESIS, 2025, 200
  • [9] Microenvironment-mediated cancer dormancy: Insights from metastability theory
    Bakhshandeh, Sadra
    Werner, Carsten
    Fratzl, Peter
    Cipitria, Amaia
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (01)
  • [10] Microenvironment-Mediated Modeling of Tumor Response to Vascular-Targeting Drugs
    Gevertz, Jana L.
    SYSTEMS BIOLOGY OF TUMOR MICROENVIRONMENT: QUANTITATIVE MODELING AND SIMULATIONS, 2016, 936 : 191 - 208